IP Library Assignment 019670/0272
Patent Assignment
Reel/Frame 019670/0272

Assignment of Assignor's Interest

Recorded: 2007-08-08 Pages: 8
Assignor
GENESENSE TECHNOLOGIES INC.
Executed: 2007-07-10
Assignee
LORUS THERAPEUTICS INC.
2 MERIDIAN ROAD, TORONTO, ONTARIO M9W 4Z7, CANADA
Covered Property (1)
Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase
Patent: 7,405,205 →
Application: 10/447,136 →
Publication: US 2004/0009948
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Sep 22, 2014
From: LORUS THERAPEUTICS INC.
To: APTOSE BIOSCIENCES INC.
Reel/Frame 033793/0620 →